Side-by-side comparison of AI visibility scores, market position, and capabilities
AI-designed mRNA 2.0 therapeutics for in vivo CAR-T cancer and autoimmune therapy; $35.8M raised with Amgen Ventures backing advancing KR-335 toward IND filing.
Kernal Biologics is a clinical-stage biotech developing AI-designed mRNA therapeutics for cancer and autoimmune diseases — using machine learning to engineer cell-type-specific mRNA sequences that direct therapeutic payloads (including CAR-T gene programs) to the right cells in vivo, enabling off-the-shelf CAR-T cancer therapy without the individualized cell extraction and ex vivo manufacturing process that makes current CAR-T treatments cost $400,000+ and require weeks of production time. The Y Combinator-backed company has raised $35.8 million including a $25 million Series A led by Hummingbird Ventures with participation from Amgen Ventures.
FP&A automation platform for growth-stage finance teams; connects to NetSuite, Salesforce, and data warehouses to automate financial modeling and budget collaboration.
Abacum is an FP&A (Financial Planning and Analysis) automation platform helping finance teams at growth-stage companies build automated financial models, track KPIs in real time, and collaborate on budget planning without manual spreadsheet maintenance. Founded in 2020 in Barcelona, Spain by Julio Martinez and Jorge Lluch, Abacum raised $30 million in Series A funding in 2022 from Benchmark and others, targeting the acute pain that finance teams feel maintaining complex, formula-linked Excel models that break when input assumptions change.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.